Redox-Responsive and Dual-Targeting Hyaluronic Acid–Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery
Authors:
- Yubin ZhangYZYubin Zhang
- Yang LiYLYang Li
- Haina TianHTHaina Tian
- Qixin ZhuQZQixin Zhu
- Fanfan WangFWFanfan Wang
- Zhongxiong FanZFZhongxiong Fan
- Zhenqing HouZHZhenqing Hou
- 5 June 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 16 (7) , 3133-3144
Abstract
The clinical translation of methotrexate (MTX) is limited because of low aqueous solubility, poor bioavailability, low uptake efficiency, and toxicity concerns. Herein, dual-acting MTX (not only targeting folate receptors, but also killing cells via inhibition of intracellular folate metabolism) and hyaluronic acid (HA, targeting CD44 receptors) were selected to covalently linked by redox-responsive disulfide bond. The synthesized prodrug (HA-SS-MTX) as a molecular structural motif could self-assemble into a simple, yet multifunctional nanoparticles (HA-SS-MTX NPs) in aqueous solution. The HA-SS-MTX NPs displayed an average diameter of ~110 nm with a uniformly spherical shape and maintained stability in different physiological media. Moreover, the HA-SS-MTX NPs could exhibit a sharp redox-dependent response for rapid structure disassembly and sequential MTX release compared to the redox-irresponsive group (HA-ADH-MTX NPs). Furthermore, the results of confocal microscopy and flow cytometry verified the nanosystems were selectively uptaken by cancer cells via folate and CD44 receptors-mediated internalization through dual-active targeting mechanism. In addition, HA-SS-MTX NPs could accumulate within tumor sites for a longer period. Notably, in vitro and in vivo the anti-tumor results demonstrated that HA-SS-MTX NPs significantly promoted the death of cancer cells and enhanced the inhibition of tumor growth while reducing the toxicity as compared to MTX and HA-ADH-MTX NPs. Therefore, the smart HA-SS-MTX NPs as the simple and efficient platform have great potential in tumor-targeting drug delivery and therapy.Keywords
Funding Information
- National Natural Science Foundation of China (31771029)
- ?Double-First Class? Foundation of Materials and Intelligent Manufacturing Discipline of Xiamen University
- Xiamen Science and Technology Project (3502Z20174071)
- Natural Science Foundation of Zhangzhou City (ZZ2016J03)
This publication has 65 references indexed in Scilit:
- Targeting c-MET by Tivantinib through synergistic activation of JNK/c-jun pathway in cholangiocarcinomaCell Death & Disease, 2019
- Bioengineered Boronic Ester Modified Dextran Polymer Nanoparticles as Reactive Oxygen Species Responsive Nanocarrier for Ischemic Stroke TreatmentACS Nano, 2018
- Cancer Cell Membrane‐Biomimetic Oxygen Nanocarrier for Breaking Hypoxia‐Induced ChemoresistanceAdvanced Functional Materials, 2017
- Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen SpeciesNano Letters, 2017
- Drug/Dye-Loaded, Multifunctional PEG–Chitosan–Iron Oxide Nanocomposites for Methotraxate Synergistically Self-Targeted Cancer Therapy and Dual Model ImagingACS Applied Materials & Interfaces, 2015
- Development of Both Methotrexate and Mitomycin C Loaded PEGylated Chitosan Nanoparticles for Targeted Drug Codelivery and Synergistic Anticancer EffectACS Applied Materials & Interfaces, 2014
- Tumour heterogeneity and cancer cell plasticityNature, 2013
- Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assayAnalytical Biochemistry, 2005
- Interaction of dihydrofolate reductase with methotrexate: Ensemble and single-molecule kineticsProceedings of the National Academy of Sciences, 2002
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983